[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
[Spin on]
[Spin off]
[Reset]
[High quality]
[Low quality]
[White background]
[Black background]
|
PDB | 5h24 Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy |
Resolution | 2.5 Å |
Binding residue (original residue number in PDB) | W103 H104 S105 K106 E107 D109 V112 Y154 S159 H160 P161 P177 I178 R201 L246 L247 L315 G316 D317 L318 K332 M336 F372 W373 Q374 L391 E392 E394 R420 |
Binding residue (residue number reindexed from 1) | W27 H28 S29 K30 E31 D33 V36 Y78 S83 H84 P85 P101 I102 R125 L170 L171 L239 G240 D241 L242 K256 M260 F296 W297 Q298 L315 E316 E318 R344 |
|